Livdelzi TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: seladelpar
Pack: Livdelzi 10 mg capsule, 30, bottle
Brand name
(ARTG)
: LIVDELZI seladelpar 10 mg capsule bottleConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
LIVDELZI is indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have an inadequate response to UDCA alone, or as monotherapy in those unable to tolerate UDCA.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Opaque, hard gelatin capsules, size 1, with light grey opaque body and a dark blue opaque cap, printed with CBAY in white ink on the cap and 10 in black ink on the body
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 48 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 30 capsules pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient seladelpar
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
